State

Minnesota product recalls

73,833 recalls have nationwide distribution and so reach Minnesota. 7,851 additional recalls listed Minnesota specifically in their distribution scope.

What the numbers show

Total: 7,851
Critical: 1,137
Severe: 2,246
Most recent: 2026-11-04

Of the 7,851 recalls naming Minnesota we have scored against our rubric, 1,137 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,246 (29%) are Severe.

Which agencies issued them

These figures cover only the 7,851 recalls whose distribution notice names Minnesota specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

57901–57925 of 81684

SevereFDA (Drugs)·D-1674-2015·2015-09-23
FDA Recalls Intrathecal Solution Due to Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling a specific intrathecal solution because an FDA inspection found GMP violations that may impact sterility.
Product
Hydromorphone 45 mg/ml + Fentanyl 10,000 mcg/ml + Bupivacaine 15 mg/ml + Baclofen 720 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1666-2015·2015-09-23
Bi-Mix Medium Injectable Recalled Due to Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Bi-Mix Medium (30/1) Injectable due to FDA inspection findings of GMP violations that may impact sterility.
Product
Bi-Mix Medium (30/1) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1802-2015·2015-09-23
Tri-Mix SUPER Injectable Recalled for Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Tri-Mix SUPER injectable due to FDA inspection findings of GMP violations that may impact sterility.
Product
Tri-Mix SUPER (28 mg/0.9 mg/37 mcg) Injectable, Sterile Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1756-2015·2015-09-23
Testosterone Cypionate Injection Recalled for Lack of Sterility Assurance
The Compounding Pharmacy of America is recalling Testosterone Cypionate 220 mg/ml Injection due to FDA inspection findings of GMP violations that impact sterility.
Product
Testosterone Cypionate 220 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1774-2015·2015-09-23
Tri-Mix Injectable Recalled for Lack of Sterility Assurance
The Compounding Pharmacy of America is recalling Tri-Mix Injectable due to FDA inspection findings of GMP violations that impact sterility.
Product
Tri-Mix (30/0.5/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1473-2015·2015-09-23
Estradiol Pellets Recalled Due to Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Estradiol 4 mg sterile pellets because FDA inspections found GMP violations that may impact sterility.
Product
Estradiol 4 mg, Sterile Pellet, The Compounding Pharmacy of America, Inc., Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1775-2015·2015-09-23
Compounded Tri-Mix Injectable Recalled for Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Tri-Mix injectable products due to FDA inspection findings of GMP violations that may impact sterility.
Product
Tri-Mix (30/0.5/10) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1684-2015·2015-09-23
Lipo-DEN III Injection Recalled for Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Lipo-DEN III Injection due to FDA inspection findings of GMP violations that may impact sterility.
Product
Lipo-DEN III Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1537-2015·2015-09-23
Hyaluronidase Injection Recalled Due to Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Hyaluronidase 150 units/ml Injection because an FDA inspection found GMP violations that may affect sterility.
Product
Hyaluronidase 150 units/ml Injection, ml, Sterile, Preservative Free, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1794-2015·2015-09-23
FDA Recalls Tri-Mix Injectable Due to Sterility Concerns
The Compounding Pharmacy of America is recalling Tri-Mix injectable products because FDA inspections found GMP violations that may affect sterility.
Product
Tri-Mix ST2/LIDO2/PGE2 0.2/0.1/0.04, Injectable, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1681-2015·2015-09-23
FDA Recalls Intrathecal Pain Medication Due to Sterility Concerns
The Compounding Pharmacy of America is recalling a specific intrathecal pain medication solution because an FDA inspection found violations that could affect the product's sterility.
Product
Hydromorphone 70 mg/ml +Fentanyl 16,000 mcg/ml + Bupivacaine 12 mg/ml + Clonidine 1,000 mcg/ml, Baclofen 900 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1804-2015·2015-09-23
FDA Recalls Tri-Mix Injectable Due to Sterility Concerns
The Compounding Pharmacy of America is recalling Tri-Mix T-102 Injectable nationwide because an FDA inspection found GMP violations that may affect sterility.
Product
Tri-Mix T-102 (17.65 mg/0.59 mg/10 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1743-2015·2015-09-23
Testosterone Sterile Pellets Recalled for Lack of Sterility Assurance
The Compounding Pharmacy of America is recalling Testosterone 12.5 mg sterile pellets due to FDA inspection findings of GMP violations that impact sterility.
Product
Testosterone 12.5 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1540-2015·2015-09-23
FDA Recalls Hydromorphone Intrathecal Solution Due to Sterility Concerns
The Compounding Pharmacy of America is recalling Hydromorphone 0.25 mg/ml Intrathecal Solution because an FDA inspection found GMP violations that may affect sterility.
Product
Hydromorphone 0.25 mg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1576-2015·2015-09-23
Compounded Injection Recalled for Lack of Sterility Assurance
The Compounding Pharmacy of America is recalling a compounded injection due to FDA-identified GMP violations that impact sterility assurance.
Product
Methylcobalamin 7.5 mg/ml + Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 50 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1728-2015·2015-09-23
Fentanyl and Bupivacaine Intrathecal Solution Recalled for Sterility Concerns
The Compounding Pharmacy of America is recalling Fentanyl and Bupivacaine Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
Product
Fentanyl 5,000 mcg/ml + Bupivacaine 40 mg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1460-2015·2015-09-23
Cyanocobalamin and B-Complex Injection Recalled for Sterility Concerns
The Compounding Pharmacy of America is recalling Cyanocobalamin and B-Complex injections due to FDA inspection findings of GMP violations that may impact sterility.
Product
Cyanocobalamin 1,000 mcg/ml + B-Complex 500 mg/ml, ml, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1809-2015·2015-09-23
Tri-Mix Injectable Recalled for Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Tri-Mix T-50 Injectable due to FDA inspection findings of GMP violations that may impact sterility.
Product
Tri-Mix T-50 8.8 mg/0.29 mg/2.9 mcg Injectable, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1718-2015·2015-09-23
Quad-Mix 4 Injectable Recalled Due to Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Quad-Mix 4 Injectable vials because FDA inspections found GMP violations that may affect sterility.
Product
Quad-Mix 4 Injectable, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1603-2015·2015-09-23
Morphine and Fentanyl Solution Recalled Due to Sterility Concerns
The Compounding Pharmacy of America is recalling Morphine and Fentanyl solution because FDA inspections found GMP violations that may affect sterility.
Product
Morphine 40 mg/ml + Fentanyl 2,000 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1710-2015·2015-09-23
FDA Recalls Morphine, Fentanyl, and Bupivacaine Solution Due to Sterility Concerns
The Compounding Pharmacy of America is recalling a sterile morphine, fentanyl, and bupivacaine solution because FDA inspections found GMP violations that may affect sterility.
Product
Morphine 50 mg/ml + Fentanyl 3,000 mcg/ml + Bupivacaine 15 mg/ml Solution, Sterile, Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1539-2015·2015-09-23
Hyaluronidase Injection Recalled for Sterility Assurance Concerns
The Compounding Pharmacy of America is recalling Hyaluronidase 175 units/ml Injection due to FDA inspection findings of GMP violations that may impact sterility.
Product
Hyaluronidase 175 units/ml Injection, ml, Sterile, Preserved, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1484-2015·2015-09-23
Fentanyl and Bupivacaine Intrathecal Solution Recalled for Sterility Concerns
The Compounding Pharmacy of America is recalling Fentanyl and Bupivacaine Intrathecal Solution due to FDA inspection findings of GMP violations that may impact sterility.
Product
Fentanyl 3,000 mcg/ml + Bupivacaine 20 mg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide
SevereNHTSA·15V594000·2015-09-23
Mitsubishi Mirage and i-MiEV Recalled for Air Bag Deployment Issues
Mitsubishi is recalling 2014 Mirages and 2012 i-MiEVs because increased resistance in the impact sensor may delay or prevent air bag deployment in a crash.
Product
MITSUBISHI — MITSUBISHI MIRAGE, I-MIEV
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1713-2015·2015-09-23
FDA Recalls Compounded Sterile Morphine and Fentanyl Solution for Sterility Concerns
The Compounding Pharmacy of America is recalling a sterile compounded solution containing morphine, fentanyl, bupivacaine, and clonidine due to FDA-identified GMP violations that may impact sterility.
Product
Morphine 60 mg/ml + Fentanyl 12,000 mcg/ml + Bupivacaine 40 mg/ml + Clonidine 1,400 mcg/ml Solution, Sterile, Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Category
Drug
Distribution
Distributed nationwide